Frank D. Goebel

1.7k total citations
30 papers, 1.2k citations indexed

About

Frank D. Goebel is a scholar working on Infectious Diseases, Virology and Physiology. According to data from OpenAlex, Frank D. Goebel has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Virology and 7 papers in Physiology. Recurrent topics in Frank D. Goebel's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV-related health complications and treatments (6 papers). Frank D. Goebel is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV-related health complications and treatments (6 papers). Frank D. Goebel collaborates with scholars based in Germany, United Kingdom and United States. Frank D. Goebel's co-authors include Johannes R. Bogner, Gerlinde M. Michl, Ravi Walli, C. Dieterle, Hans Jäger, Thomas Demant, R Landgraf, Schlomo Staszewski, Volker Klauß and Ian James and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Ophthalmology.

In The Last Decade

Frank D. Goebel

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank D. Goebel Germany 12 684 671 515 196 160 30 1.2k
Brian Clagett United States 13 617 0.9× 837 1.2× 744 1.4× 321 1.6× 175 1.1× 23 1.5k
Miguel López-Dupla Spain 20 262 0.4× 209 0.3× 200 0.4× 325 1.7× 136 0.8× 59 904
Christopher J. Lahart United States 10 343 0.5× 275 0.4× 63 0.1× 224 1.1× 52 0.3× 13 627
Denise C. Hsu United States 16 303 0.4× 368 0.5× 198 0.4× 222 1.1× 113 0.7× 40 752
Alicja Wiercińska‐Drapało Poland 17 334 0.5× 232 0.3× 173 0.3× 459 2.3× 344 2.1× 119 1.3k
Benvenuto Grisorio Italy 19 295 0.4× 188 0.3× 360 0.7× 527 2.7× 94 0.6× 27 1.2k
Jean-Guy Baril Canada 17 751 1.1× 751 1.1× 431 0.8× 245 1.3× 155 1.0× 51 1.3k
María Ángeles Jiménez‐Sousa Spain 20 286 0.4× 138 0.2× 158 0.3× 732 3.7× 276 1.7× 127 1.5k
Shahin Gharakhanian France 14 697 1.0× 401 0.6× 387 0.8× 1.0k 5.3× 164 1.0× 29 1.9k
H. Deicher Germany 17 144 0.2× 91 0.1× 253 0.5× 137 0.7× 73 0.5× 61 1.0k

Countries citing papers authored by Frank D. Goebel

Since Specialization
Citations

This map shows the geographic impact of Frank D. Goebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank D. Goebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank D. Goebel more than expected).

Fields of papers citing papers by Frank D. Goebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank D. Goebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank D. Goebel. The network helps show where Frank D. Goebel may publish in the future.

Co-authorship network of co-authors of Frank D. Goebel

This figure shows the co-authorship network connecting the top 25 collaborators of Frank D. Goebel. A scholar is included among the top collaborators of Frank D. Goebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank D. Goebel. Frank D. Goebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmid, Holger, Małgorzata Tokarska-Schlattner, Laurence Kay, et al.. (2012). Macro Ck2 Accumulation in Tenofovir-Treated HIV Patients is Facilitated by Ck Oligomer Stabilization but is Not Predictive for Pathology. Antiviral Therapy. 18(2). 193–204. 3 indexed citations
2.
3.
Jülg, Boris, et al.. (2007). Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.. PubMed. 12(2). 54–60. 10 indexed citations
4.
Bickel, Markus, Stephan Zangos, Thomas A. Lutz, et al.. (2007). Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophy. Scandinavian Journal of Infectious Diseases. 40(1). 36–39. 1 indexed citations
5.
6.
Horster, Sophia & Frank D. Goebel. (2006). Serious Doubts on Safety and Efficacy of CCR5 Antagonists. Infection. 34(2). 110–113. 2 indexed citations
7.
Jordan, Jamie C., Pedro Cahn, Frank D. Goebel, et al.. (2005). Abacavir Compared to Protease Inhibitors as Part of HAART Regimens for Treatment of HIV Infection: Patient Satisfaction and Implications for Adherence. AIDS Patient Care and STDs. 19(1). 9–18. 22 indexed citations
8.
Fätkenheuer, Gerd, Anton Pozniak, Margaret Johnson, et al.. (2005). Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nature Medicine. 11(11). 1170–1172. 386 indexed citations
9.
Horster, Sophia, et al.. (2003). Uncommon Hematologic Malignancies. Journal of Clinical Oncology. 21(22). 4248–4249. 4 indexed citations
10.
Walli, Ravi, et al.. (1999). Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. Research in Experimental Medicine. 199(5). 253–262. 55 indexed citations
11.
Walli, Ravi, Gerlinde M. Michl, Thomas Demant, et al.. (1998). Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS. 12(15). F167–F173. 431 indexed citations
12.
Rolinski, Boris, et al.. (1997). Absorption and Elimination Kinetics of Zidovudine in the Cerebrospinal Fluid in HIV-1-Infected Patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(3). 192–197. 38 indexed citations
13.
Goebel, Frank D., et al.. (1995). Sicca Syndrome in Patients Infected with the Human Inununodeficiency Virus. Ophthalmology. 102(9). 1319–1324. 26 indexed citations
14.
Naber, Dieter, et al.. (1995). [Incidence and etiology of psychotic disorders in HIV infected patients].. PubMed. 66(5). 367–71. 1 indexed citations
15.
Schielke, Eva, Klaus Tatsch, Johannes R. Bogner, et al.. (1993). Brain HMPAO-SPECT and ocular microangiopathic syndrome in HIV-1-infected patients. AIDS. 7(12). 1589–1594. 12 indexed citations
16.
Füeßl, H. S., Y. Yiangou, M.A. Ghatei, Frank D. Goebel, & S.R. Bloom. (1990). Effect of synthetic human glucose‐dependent insulinotropic polypeptide (hGIP) on the release of insulin in man. European Journal of Clinical Investigation. 20(5). 525–529. 9 indexed citations
17.
Ehrenreich, Hannelore, et al.. (1987). Potentiation of the hCRF-induced release of ACTH in man by an opioid antagonist. Journal of Molecular Medicine. 65(10). 453–457. 9 indexed citations
18.
Goebel, Frank D., et al.. (1987). Sekundäre Gicht und Pseudo-Bartter-Syndrom bei Frauen mit Laxantienabusus. Journal of Molecular Medicine. 65(17). 833–839. 5 indexed citations
19.
Goebel, K. M., et al.. (1975). Red Cell Metabolism in Transient Haemolytic Anaemia Associated with Zieve's Syndrome. European Journal of Clinical Investigation. 5(1). 83–91. 10 indexed citations
20.
Goebel, K. M. & Frank D. Goebel. (1972). Hemolytic Anemia and Pancytopenia in Glutathione Reductase Deficiency: Further Experience with Riboflavin. Acta Haematologica. 47(5). 292–296. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Clagett Breakdown of academic impact, for papers by Miguel López-Dupla Breakdown of academic impact, for papers by Christopher J. Lahart Breakdown of academic impact, for papers by Denise C. Hsu Breakdown of academic impact, for papers by Alicja Wiercińska‐Drapało Breakdown of academic impact, for papers by Benvenuto Grisorio Breakdown of academic impact, for papers by Jean-Guy Baril Breakdown of academic impact, for papers by María Ángeles Jiménez‐Sousa Breakdown of academic impact, for papers by Shahin Gharakhanian Breakdown of academic impact, for papers by H. Deicher
Rankless by CCL
2026